(Q44064898)

English

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lorne F Forster

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Grace Stewart

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dorothy Bedford

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

James P Stewart

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Elizabeth Rogers

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

James Shepherd

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Chris J Packard

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Muriel J Caslake

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

129-145

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Comparison of statins in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900052-7

7 January 2021

Identifiers

10.1016/S0021-9150(02)00052-7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44064898&oldid=2106184773"